Works by Brønden, Andreas
Results: 32
Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e660, doi. 10.1210/clinem/dgae261
- By:
- Publication type:
- Article
Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta‐analyses‐driven approach.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 8, p. 1, doi. 10.1111/dme.15157
- By:
- Publication type:
- Article
Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2017, p. 4153, doi. 10.1210/jc.2017-01091
- By:
- Publication type:
- Article
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects.
- Published in:
- Patient Preference & Adherence, 2024, v. 18, p. 373, doi. 10.2147/PPA.S419304
- By:
- Publication type:
- Article
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Increased gallbladder emptying and reduced GLP‐1 response in pregnancy with and without gestational diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 697, doi. 10.1111/dom.16064
- By:
- Publication type:
- Article
Elucidating the glucose‐lowering effect of the bile acid sequestrant sevelamer.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1252, doi. 10.1111/dom.15421
- By:
- Publication type:
- Article
Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1632, doi. 10.1111/dom.15017
- By:
- Publication type:
- Article
Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2557, doi. 10.1111/dom.13420
- By:
- Publication type:
- Article
Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1623, doi. 10.1111/dom.13272
- By:
- Publication type:
- Article
The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 362, doi. 10.1111/dom.13080
- By:
- Publication type:
- Article
Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1214, doi. 10.1111/dom.12946
- By:
- Publication type:
- Article
Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 915, doi. 10.1111/dom.12911
- By:
- Publication type:
- Article
Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 10, p. 955, doi. 10.1111/dom.12697
- By:
- Publication type:
- Article
Response to "Advancing understanding of metabolic consequences of cholecystectomy: review reflection".
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 6, p. L11, doi. 10.1093/ejendo/lvae153
- By:
- Publication type:
- Article
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 2, p. 192, doi. 10.1093/ejendo/lvae095
- By:
- Publication type:
- Article
The bile–gut axis and metabolic consequences of cholecystectomy.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 4, p. R1, doi. 10.1093/ejendo/lvae034
- By:
- Publication type:
- Article
Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?
- Published in:
- BMC Endocrine Disorders, 2009, v. 9, p. 1, doi. 10.1186/1472-6823-9-7
- By:
- Publication type:
- Article
The zinc transporter ZNT3 co-localizes with insulin in INS-1E pancreatic beta cells and influences cell survival, insulin secretion capacity, and ZNT8 expression.
- Published in:
- BioMetals, 2016, v. 29, n. 2, p. 287, doi. 10.1007/s10534-016-9915-7
- By:
- Publication type:
- Article
Clinical pharmacology of imeglimin for the treatment of type 2 diabetes.
- Published in:
- Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 8, p. 871, doi. 10.1080/14656566.2020.1729123
- By:
- Publication type:
- Article
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
- Published in:
- Expert Opinion on Pharmacotherapy, 2019, v. 20, n. 5, p. 501, doi. 10.1080/14656566.2019.1571040
- By:
- Publication type:
- Article
Exenatide: pharmacokinetics, clinical use, and future directions.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 6, p. 555, doi. 10.1080/14656566.2017.1282463
- By:
- Publication type:
- Article
Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SLC30A3 Responds to Glucose- and Zinc Variations in ß- Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005684
- By:
- Publication type:
- Article
770-P: The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-770-P
- By:
- Publication type:
- Article
103-OR: The Glucagon-Like Peptide-1 Analog, Liraglutide Is a Safe and Effective Treatment of Bile Acid Malabsorption: A Proof of Concept Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-103-OR
- By:
- Publication type:
- Article
1662-P: Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1662-P
- By:
- Publication type:
- Article
23-OR: The Effect of 14-Day Atorvastatin Treatment on Postprandial Glucose Metabolism in Healthy Males—A Link to Why Statin Therapy Increases the Risk of Type 2 Diabetes?
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-23-OR
- By:
- Publication type:
- Article
1982-P: Glucagon-Like Peptide-2 Inhibits Postprandial Gallbladder Emptying in Healthy Male Individuals—A Randomized, Double-Blinded, Placebo-Controlled Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1982-P
- By:
- Publication type:
- Article
1980-P: A Characterization of Postprandial Glucose Metabolism and Incretin Hormone Responses in Patients with Bile Acid Malabsorption.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1980-P
- By:
- Publication type:
- Article